Why is Organigram (TSX: OGI) stock trending?

Be the First to Comment Read

Why is Organigram (TSX: OGI) stock trending?

Why is Organigram (TSX: OGI) stock trending?
Image source: © 2022 Kalkine Media Inc

Highlights

  • Organigram Holdings Inc (TSX: OGI) has been turning heads in the Canadian markets as its stock swelled by roughly 11 per cent on Thursday, March 24, in the light of some corporate updates and new development in its pot products portfolio.
  • The C$ 658-million market cap company announced that it strengthened its market position with the acquisition of Laurentian Holdings, a Quebec-based company, in December last year.
  • In addition, the cannabis firm has also launched two new strains and four new products.

Organigram Holdings Inc (TSX: OGI) has been turning heads in the Canadian markets as its stock swelled by roughly 11 per cent on Thursday, March 24, in the light of some corporate updates and new development in its pot products portfolio.

Organigram Holdings is a Moncton, New Brunswick-headquartered firm that holds the license to produce indoor-growth cannabis for medical and recreational purposes in Canada. The firm is focused on building overseas business partnerships.

So, let us find out what the pot maker said in its latest announcement and discuss its overall performance in detail.

 

What did Organigram Holdings (TSX: OGI) say?

The C$ 658-million market cap company announced that it strengthened its market position with the acquisition of Laurentian Holdings, a Quebec-based company, in December last year. 

The company added that through its national distribution and sales network, Laurentian products are "expected" to be accessible in nine Canadian provinces in the upcoming three months.

Its Moncton facility's keif production surpassed initial targets on a quality and quantity basis and is now available in its Laurentia facility to enhance hash production.

In addition, the cannabis firm has also launched two new strains and four new products.

Also read: Aurora Cannabis (TSX: ACB) to acquire TerraFarma: Is it a buy stock?

 

 

Organigram Holdings (TSX: OGI) 's financial performance in Q1 FY2022

The Canadian pot maker increased its net revenue by 57 per cent year-over-year (YoY) to C$ 30.37 million in Q1 FY2022. It cut down its Q1 net loss from C$ 34.33 million in 2021 to C$ 1.3 million in FY2022.

 Organigram Holdings Inc (TSX: OGI)’s Q1 FY2022 results

 

Also read: HEXO & Nova Cannabis (NOVC): 2 TSX pot stock firms with recent reports

 

Organigram Holdings (TSX: OGI) 's stock performance

Having closed at C$ 2.10 on Thursday, OGI stock was trading lower at C$ 2.09 apiece at 10:28 AM EST on Friday, March 25. The cannabis stock zoomed by nearly 18 per cent in the last month.

 

Bottomline

Organigram Holdings said it continued a "strong" market share growth trajectory in the Canadian cannabis market.

Investors interested in pot stocks, however, should be aware of the latest developments in the cannabis market to reap benefits in the long run. Also, it is necessary to evaluate the company's growth potential before making any investment call.

Disclaimer

Speak your Mind

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK